| Title | Date | PubMed ID |
|---|
| The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain. | 2016 Dec | 26666664 |
| Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells. | 2015 | 26352258 |
| Farnesyltransferase and geranylgeranyltransferase I: structures, mechanism, inhibitors and molecular modeling. | 2015 Feb | 25450772 |
| Prenylation is required for polar cell elongation, cell adhesion, and differentiation in Physcomitrella patens. | 2014 May | 24634995 |
| Targeted reengineering of protein geranylgeranyltransferase type I selectivity functionally implicates active-site residues in protein-substrate recognition. | 2014 Jan 21 | 24344934 |
| Restricted substrate specificity for the geranylgeranyltransferase-I enzyme in Cryptococcus neoformans: implications for virulence. | 2013 Nov | 24014765 |
| Geranylgeranyltransferase I mediates BDNF-induced synaptogenesis. | 2013 Jun | 23534605 |
| Geranylgeranyltransferase I promotes human glioma cell growth through Rac1 membrane association and activation. | 2013 Jan | 23073905 |
| Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle. | 2012 Feb 15 | 22160308 |
| Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I. | 2011 Jun | 21440964 |